Christopher Patronella
Houston, TXNPI 1023183712
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $28,756 of the $38,142 with a category attached, or 75.4%. AbbVie accounts for 81.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $29,883 and has fallen 94.8% since, to $1,549 in 2025.
Across 156 payments — averaging $244.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- Revance Therapeutics, Inc.$2K
- Mentor Worldwide LLC$927
- Sientra, Inc.$923
- Merz North America, Inc.$669
- Motiva USA, LLC$530
- plus $2K from 12 others
Across 2 payments — averaging $145.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$290
What the payments were for
- Food & beverage$9,17524%
- Gifts$28,75675%
- Other$2111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $31,217 |
| Revance Therapeutics, Inc. | 23 | $1,706 |
| Mentor Worldwide LLC | 12 | $927 |
| Sientra, Inc. | 7 | $923 |
| Merz North America, Inc. | 6 | $669 |
| Motiva USA, LLC | 6 | $530 |
| Bard Peripheral Vascular, Inc. | 4 | $469 |
| Davol Inc. | 3 | $454 |
| Galderma Laboratories, L.p. | 8 | $341 |
| TELA Bio, Inc. | 3 | $290 |
| Integra Lifesciences Corporation | 1 | $211 |
| Pacira Pharmaceuticals Incorporated | 6 | $142 |
| Johnson & Johnson | 7 | $124 |
| Acacia Pharma Inc | 2 | $43 |
| Medtronic | 1 | $33 |
| Medline Industries LP | 1 | $25 |
| Apyx Medical Corporation | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$29,034
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$887
- MENTOR MemoryGel Resterilizable Gel Sizer$789
- DAXXIFY$726
- NATRELLE SALINE-FILLED BREAST IMPLANTS$544
- Phasix Mesh$454
- Motiva Implant Matrix$422
- OviTex 2S$264
- BOTOX$249
- DuraSorb Monofilament Mesh$211
- MENTOR CPX 2 Breast Tissue Expander$149
- ARTOURA Breast Tissue Expander$111
- BOTOX COSMETIC$109
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $197 |
| Cephalexin | 26 | $187 |
| Ondansetron Hcl | 28 | $121 |
| ValacyclovirValacyclovir Hcl | 13 | $105 |
| Gabapentin | 32 | $104 |
| Methylprednisolone | 15 | $62 |
| Alprazolam | 23 | $61 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.